(Q41105715)

English

Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor

scientific article published on June 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ray P

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Ghosh SK

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Zhang DH

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Ray A

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

409

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

79-85

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Cloning of a differentially expressed I kappa B-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Rapid enhancement of beta 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Inhibition of Estrogen Receptor Activity by the Tumor Promoter 12-O-Tetradeconylphorbol-13-Acetate: A Molecular Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

A new technique for the assay of infectivity of human adenovirus 5 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

21 January 2018

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

7 January 2021

Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

7 January 2021

Functional domains of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

7 January 2021

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

7 January 2021

Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900487-0

7 January 2021

Identifiers

10.1016/S0014-5793(97)00487-0

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41105715&oldid=2093999456"